These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1066 related articles for article (PubMed ID: 30993707)
21. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
22. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway. Kong LY; Xue M; Zhang QC; Su CF Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945 [TBL] [Abstract][Full Text] [Related]
23. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Xu M; Qin S; Cao F; Ding S; Li M Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483 [TBL] [Abstract][Full Text] [Related]
27. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways. Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273 [TBL] [Abstract][Full Text] [Related]
28. microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1. Gao R; Feng Q; Tan G Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189740 [No Abstract] [Full Text] [Related]
29. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer. Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway. Xiao R; Wang H; Yang B Bioengineered; 2021 Dec; 12(2):10596-10607. PubMed ID: 34895048 [TBL] [Abstract][Full Text] [Related]
31. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer. Yang F; Shao C; Wei K; Jing X; Qin Z; Shi Y; Shu Y; Shen H J Cell Physiol; 2019 Dec; 234(12):23596-23607. PubMed ID: 31236953 [TBL] [Abstract][Full Text] [Related]
32. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells. Yin K; Yin W; Wang Y; Zhou L; Liu Y; Yang G; Wang J; Lu J Oncotarget; 2016 Apr; 7(17):24537-48. PubMed ID: 27014911 [TBL] [Abstract][Full Text] [Related]
33. The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway. Zhang J; Wang L; Jiang J; Qiao Z J Cell Biochem; 2020 Dec; 121(12):4699-4710. PubMed ID: 33135285 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways. Wang Y; Liu BG; Zhou CX Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337 [TBL] [Abstract][Full Text] [Related]
35. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro. Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395 [TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway. Jiang H; Li X; Wang W; Dong H BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233 [TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Kong Q; Qiu M Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3. You A; Fu L; Li Y; Li X; You B Cell Cycle; 2020 May; 19(10):1105-1121. PubMed ID: 32308106 [TBL] [Abstract][Full Text] [Related]
40. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]